Suppr超能文献

利用分子间 G-四链体的空间限制效应加速 CRISPR/Cas12a 的激活,增强了对 PML/RARA 融合基因的超灵敏检测。

Harnessing intermolecular G-quadruplex-based spatial confinement effect for accelerated activation of CRISPR/Cas12a empowers ultra-sensitive detection of PML/RARA fusion genes.

机构信息

Medical Research Center, Fujian Maternity and Child Health Hospital, College of Clinical Medicine for Obstetrics and Gynecology and Pediatrics, Fujian Medical University, Fuzhou, Fujian, 350000, PR China; NHC Key Laboratory of Technical Evaluation of Fertility Regulation for Non-Human Primate (Fujian Maternity and Child Health Hospital), Fuzhou, Fujian, 350000, PR China.

School of Chemistry and Materials Engineering, Fuyang Normal University, Fuyang, Anhui, 236037, PR China.

出版信息

Anal Chim Acta. 2024 Jan 25;1287:342108. doi: 10.1016/j.aca.2023.342108. Epub 2023 Dec 6.

Abstract

Accurate detection and classification of the three isoforms of PML/RARA genomic fragments are crucial for predicting disease progression, stratifying risk, and administering precise drug therapies in acute promyelocytic leukemia (APL). In this study, we have developed a highly specific nucleic acid detection platform capable of quantifying the long isoform of the three main PML-RARA isoforms at a constant temperature. This platform integrates the strengths of the CRISPR/Cas12a nuclease-based method and the rolling circle amplification (RCA) technique. Notably, the RCA-assisted CRISPR/Cas12a trans-cleavage system incorporates a spatial confinement effect by utilizing intermolecular G-quadruplex structures. This innovative design effectively enhances the local concentration of CRISPR/Cas12a, thereby accelerating its cleaving efficiency towards reporter nucleic acids and enabling the detection of PML/RARA fusion gene expression through spectroscopy. The robust detection of PML/RARA fusion gene from human serum samples validates the reliability and potential of this platform in the screening, diagnosis, and prognosis of APL cases. Our findings present an approach that holds significant potential for the further development of the robust CRISPR/Cas sensor system, offering a rapid and adaptable paradigm for APL diagnosis.

摘要

准确检测和分类 PML/RARA 基因组片段的三种异构体对于预测疾病进展、分层风险以及在急性早幼粒细胞白血病 (APL) 中进行精确的药物治疗至关重要。在这项研究中,我们开发了一种高度特异的核酸检测平台,能够在恒温下定量检测三种主要 PML/RARA 异构体的长异构体。该平台集成了基于 CRISPR/Cas12a 核酸酶的方法和滚环扩增 (RCA) 技术的优势。值得注意的是,RCA 辅助的 CRISPR/Cas12a 转切割系统利用分子间 G-四链体结构产生空间限制效应。这种创新设计有效地提高了 CRISPR/Cas12a 的局部浓度,从而加速其对报告核酸的切割效率,并通过光谱法检测 PML/RARA 融合基因的表达。从人血清样本中对 PML/RARA 融合基因的稳健检测验证了该平台在 APL 病例筛查、诊断和预后中的可靠性和潜力。我们的研究结果为进一步开发稳健的 CRISPR/Cas 传感器系统提供了一种方法,为 APL 诊断提供了一种快速和适应性强的范例。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验